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The synthesis of novel fluorescent materials represents a very important step to obtain labeled nanoformulations in
order to evaluate their biological behavior. The strategy of conjugating a fluorescent dye with triacylglycerol allows that
either particles differing regarding supramolecular structure, i.e., nanoemulsions, nanocapsules, lipid-core nanocapsules,
or surface charge, i.e., cationic nanocapsules and anionic nanocapsules, can be tracked using the same labeled material.
In this way, a rhodamine B-conjugated triglyceride was obtained to prepare fluorescent polymeric nanocapsules.
Different formulations were obtained, nanocapsules (NC) or lipid-core nanocapsules (LNC), using the labeled oil
and Eudragit RS100, Eudragit S100, or poly(caprolactone) (PCL), respectively. The rhodamine B was coupled with
the ricinolein by activating the carboxylic function using a carbodiimide derivative. Thin layer chromatography,
proton nuclear magnetic resonance (1H-NMR), Fourier transform infrared spectroscopy (FTIR), UV-vis, and fluorescence
spectroscopy were used to identify the new product. Fluorescent nanocapsule aqueous suspensions were prepared
by the solvent displacement method. Their pH values were 4.6 (NC-RS100), 3.5 (NC-S100), and 5.0 (LNC-PCL). The
volume-weighted mean diameter (D4.3) and polydispersity values were 150 nm and 1.05 (NC-RS100), 350 nm and
2.28 (NC-S100), and 270 nm and 1.67 (LNC-PCL). The mean diameters determined by photon correlation spectroscopy
(PCS) (z-average) were around 200 nm. The zeta potential values were +5.85 mV (NC-RS100), −21.12 mV (NC-S100),
and −19.25 mV (LNC-PCL). The wavelengths of maximum fluorescence emission were 567 nm (NC-RS100 and
LNC-PCL) and 574 nm (NC-S100). Fluorescence microscopy was used to evaluate the cell uptake (human macrophage
cell line) of the fluorescent nanocapsules in order to show the applicability of the approach. When the cells were
treated with the fluorescent nanocapsules, red emission was detected around the cell nucleus. We demonstrated
that the rhodamine B-conjugated triglyceride is a promising new material to obtain versatile dye-labeled nanocarriers
presenting different chemical nature in their surfaces.
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Polymeric nanocapsules, which are nanoscale particles
prepared by self-assembling methods and composed of
a polymeric wall surrounding an oily core, have been
studied to direct drugs toward their targeted thera-
peutic site of action [1-4]. Due to the lipophilic core, the
entrapment of hydrophobic drugs in nanocapsules is more
efficient in comparison with polymeric nanospheres [1,5].
In addition, nanocapsules are more suitable for prolonged
release during the sustained phase [6]. Polymeric nano-
capsules are referred to as lipid-core nanocapsules when
sorbitan monostearate is used together with the triacyl-
glycerol to prepare the nanocapsules forming an organo-
gel as core [7-9]. In general, when an active substance is
entrapped in a carrier, the mechanism of action is not only
dependent on the interactions of the substance with the
cells and/or tissues but also on the behavior of the carrier
within the organism [10].
The fluorescence phenomenon involves the absorption
of light at a particular wavelength and the emission of
electromagnetic radiation at higher wavelengths, in the
near ultraviolet-visible region, which makes it a technique
of high sensitivity where very low concentrations can
be detected [10]. Fluorescent techniques can be applied
to verify the location of the nanoparticles within cells
or their mechanisms of interaction with cells or tissues
[11-15]. For this purpose, a fluorescent dye must be
physically entrapped within [16,17] or chemically bound
to [12,18,19] the nanocarriers. In the latter case, greater
stability of the dye-particle complex can be achieved, and
the kinetics of the dye release from the particle should be
slower, reducing the possibility of false results.
Therefore, the synthesis of the fluorescent materials used
to prepare nanoformulations represents a very important
step in relation to evaluating their biological behavior.
With regard to the use of fluorescent dyes chemically
bound to nanocapsules, few studies involving the label-
ing of the polymeric wall are available [12,18,20-22]. In
this regard, it should be noted that, depending on the
chemical characteristics of the polymer, labeling the
polymer used to prepare the particles with a fluorescent
dye can change the surface nature of the nanocarrier.
The alternative of labeling a triacylglycerol can allow
the obtainment of diverse fluorescent dye-labeled nano-
carriers such as nanoemulsions, nanostructured lipid
carriers, polymeric nanocapsules, and lipid-core nano-
capsules. Additionally, by labeling the lipophilic core,
versatile nanocarriers can be obtained, non-ionic, cationic,
or anionic polymeric nanocapsules. Rhodamine B was
chosen as the fluorescent dye for use in this study, due to
the high fluorescence quantum efficiency and low cost.
Castor oil (CAO) was chosen as the reactant since its
major component, ricinolein, has three hydroxyl groups in
its molecule which can react with the carboxyl group ofrhodamine B. In order to study whether fluorescent nano-
particles with different surface characteristics could be
obtained, the novel fluorescent product was the core
material of Eudragit RS100 or Eudragit S100 nanocapsules
(NC), which have cationic and anionic surfaces, respect-
ively. To verify if different supramolecular structure could
also be obtained, fluorescent lipid-core nanocapsules (LNC)
were prepared using sorbitan monostearate and the novel
rhodamine B triacylglycerol conjugate as core and poly(ε-
caprolactone) as interfacial polymer. To investigate if
the fluorescent-labeled NC and LNC could be observed
by fluorescence microscopy, the nanoparticle uptake was
evaluated using a human macrophage cell line.
Methods
Materials
Castor oil was kindly donated by Campestre (São Bernardo
do Campo, Brazil). Eudragit S100® and Eudragit RS100®
were obtained from Almapal (São Paulo, Brazil). Rhoda-
mine B, 4-(N,N-dimethyl)aminopyridine (DMAP), 1-ethyl-
3-(3-dimethylaminopropyl)carbodiimide hydrochloride
(EDCI.HCl), poly(ε-caprolactone) with weight average
molar mass (Mw) of 14 kg mol−1 (PCL14), sorbitan mono-
stearate (Span® 60), and phorbol 12-myristate 13-acetate
(PMA) were purchased from Sigma-Aldrich (Sao Paulo,
Brazil). Poly(ε-caprolactone) with Mw= 116 kg mol−1
(CapaTM 6500) (PCL116) was kindly donated by Perstorp
(Toledo, OH, USA). Capric/caprylic triglyceride (CCT)
was acquired from Alpha Quimica (Porto Alegre, Brazil).
Polysorbate 80 and sorbitan monooleate (Span 80®) were
supplied by Delaware (Porto Alegre, Brazil). RPMI 1640,
penicillin/streptomycin, Fungizone®, and 0.5% trypsin/
EDTA solution were obtained from Gibco (Gibco BRL,
Carlsbad, CA, USA). Fetal bovine serum (FBS) was
obtained from Cultilab (Cultilab, Campinas, SP, Brazil).
UltraCruz® mounting medium for fluorescence studies
with DAPI was supplied by Santa Cruz Biotechnology,
Inc. (Santa Cruz, CA, USA). The acetonitrile (ACN)
used in the fluorescence measurements was spectro-
scopic grade. All other reagents were of analytical grade.
Reagents and solvents were used as received, with the
exception of dichloromethane, which was distilled after
drying with calcium hydride under reflux.
Synthesis and characterization of rhodamine B-labeled
triglyceride (1)
CAO, whose main component is ricinolein (the triglyceride
of ricinoleic acid, approximately 90%) [23], was covalently
coupled with a fluorescent dye, rhodamine B (RhoB).
Briefly, rhodamine B (1.91 g) and DMAP (0.49 g) were
dissolved in dry dichloromethane (30 mL) at room temp-
erature under argon. After 40 min of stirring, EDCI.HCl
(0.82 g) dissolved in dry dichloromethane (12 mL) was
added to the reaction medium cooled in an ice bath. After
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dichloromethane (4 mL) was then added. The reaction
medium was kept under stirring for 2 days in an argon
atmosphere at room temperature. After this period,
dichloromethane (30 mL) was added to the organic phase,
and the extraction was carried out with aqueous solutions
of firstly 1 mol L−1 HCl (3 × 40 mL) and then saturated
NaHCO3 (3 × 40 mL). The organic phase was extracted
with water (6 × 40 mL), dried under magnesium sulfate
anhydrous, filtered, and evaporated under reduced pres-
sure. The fluorescent product was purified by column
chromatography using silica gel (60 to 200 mesh) and
CHCl3 as eluent. The product 1 was obtained as an oil.
After purification, the process yielded 1.0 g of product 1.
The product 1 was characterized by thin layer chroma-
tography (TLC), Fourier transform infrared spectroscopy
(FTIR), proton nuclear magnetic resonance (1H-NMR), size
exclusion chromatography (SEC), UV-vis spectroscopy,
and spectrofluorimetry. The TLC was performed using
dichloromethane/methanol (9:1, v/v) as eluent and an
aluminum sheet (Merck, Whitehouse Station, NJ, USA)
covered with silica gel 60 (70 to 230 mesh) as stationary
phase. The bands were revealed under UV light at 365 nm
(BOIT-LUB01, Boitton, Brazil). FTIR spectra were recorded
on a Varian® 640-IR spectrophotometer (Palo Alto, CA,
USA) from 4,000 to 400 cm−1 (100 scans, 2 cm−1 reso-
lution), using sodium chloride crystals. FTIR: 3,390 cm−1
(OH stretching), 2,940 and 2,850 cm−1 (CH2, asymmetric
and symmetric stretching), and 1,740 cm−1 [C =O (ester)].
SEC analysis was carried out using a Viscotek® VE 2001
chromatograph with a Viscotek® TDA 302 triple detector
and PS/DVB column (Malvern Instruments, Westborough,
MA, USA). The purified product 1 and raw castor oil were
dissolved in tetrahydrofurane, filtered (0.45 μm), and
analyzed using polystyrene as reference. The product 1
was diluted in ACN and the maximum absorption wave-
length (λab) was evaluated by UV-vis spectroscopy using a
spectrophotometer (Shimadzu® UV-1601PC, Nakagyo-ku,
Kyoto, Japan). The λab value was used to determine the
maximum emission wavelength (λmax-em) by fluorimetry
with a spectrofluorometer (Cary® 100, Agilent, Santa Clara,
CA, USA).
The amount of rhodamine B residues chemically bound
to ricinolein presented in the product 1 was quantified
by the standard addition method using a UV-visible
spectrofluorometer (Cary® 100, Agilent). Firstly, an ethanol
solution of RhoB was prepared (2.25 μmol L−1) and
aliquots of this solution were diluted with ACN in
volumetric flasks. Calibration curves were constructed
within a range of 0.108 to 0.539 μmol L−1. A fixed
concentration of the product 1 (0.152 mg mL−1) was
maintained in all samples used to construct the calibration
curve. The fluorescence intensity (If ) was measured using
a rectangular cuvette (Hellma Quartz Suprasil®, 10 mm,Sigma-Aldrich) with the maximum excitation (λmax-ex)
and λem wavelengths observed for the product 1. The
If was plotted as a function of the molar concentration
of rhodamine B. The linear coefficient value for the
linear regression corresponded to the amount of RhoB
presented in purified product 1. The experiment was
replicated three times.
Preparation of the fluorescent nanocapsules
The fluorescent-labeled polymeric nanocapsules were
prepared by the solvent displacement method [8,24]. The
polymers Eudragit RS100 and Eudragit S100 were used
to prepare the nanocapsule formulations NC-RS100
[25] and NC-S100 [26], respectively, and the polymer
poly(ε-caprolactone) (PCL) was used to obtain the lipid-
core nanocapsule formulation LNC-PCL [27]. To prepare
the nanocapsule formulations (NC-RS100 and NC-S100),
an organic phase (27 mL of acetone), containing the poly-
mer (100.0 mg), CCT/product 1 (9:1, w/w) (333 μL), and
sorbitan monooleate (76.6 mg) (except for NC-RS100),
was injected using moderate stirring into a polysorbate
80 aqueous phase (76.6 mg in 53 mL). The organic
solvent was removed by evaporating the suspension
under reduced pressure. The suspension was evaporated
until a final volume of 10 mL. The LNC-PCL formulation
was obtained by the same procedure. However, in this
case, the organic phase was composed of the polymers,
PCL116 (90.0 mg) and PCL14 (10.0 mg), CCT/product 1
(9:1, w/w) (160 μL), and sorbitan monostearate (40.0 mg)
dissolved in acetone (27 mL). Three batches of each
formulation were prepared.
Characterization of the fluorescent-labeled nanocapsules
The pH of the formulations was measured without dilution
of the suspensions using a potentiometer, model B474
(Micronal, Brazil). Laser diffraction analysis was performed
with a Malvern Mastersizer® 2000 instrument (Malvern
Instruments, Worcestershire, UK) and used to determine
the particle size distribution profile, volume-weighted
mean diameter (D4.3), and polydispersity (SPAN). Photon
correlation spectroscopy (PCS) was used to characterize
the nanometric population by determining the average
diameter (z-average) and polydispersity index. Electrophor-
etic mobility (EM) analysis was performed to determine the
zeta potential values. PCS and EM analyses were performed
using a ZetaSizer ZS (Malvern), and the formulations were
previously diluted (500-fold) in pre-filtered ultrapure water
or a 10 mM NaCl solution (pH = 5.65 ± 0.07), respectively.
The concentration of particles (particles per mL) in each
formulation was evaluated by nanoparticle tracking ana-
lysis (NTA) with a NanoSight LM10 system (NanoSight,
Amesbury, UK), equipped with a sample chamber and a
640-nm laser. For the analysis, the formulations were
diluted (5,000-fold) in ultrapure water to obtain samples
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sample chamber with a syringe. Having in mind that NTA
analysis can lack in quality of results when polydisperse
systems are analyzed, the same parameters were used for
the records and process of each sample. The records were
taken over 60 s using a camera shutter of 207 and gain of
177. The data were subsequently analyzed using NTA 2.3
Build 0011 RC1 software (gain of 1.56, blur of 3 × 3, and
min particle size of 50 nm). Particles moving under
Brownian motion are identified and tracked individually
by the software which gives the particle concentration of
the sample.
The fluorescence spectra of the formulations were in-
vestigated by fluorimetry with direct analysis or after
diluting (10-fold) in ACN (1 mL of the formulation in
10 mL of acetonitrile) using triangular rectangular cuvettes
(Hellma Quartz Suprasil®, 10 mm, Sigma-Aldrich) for
the measurements. For comparison purposes, samples
containing 160 μL (same quantity contained in 10 mL
of the LNC-PCL formulation) or 333 μL (same quantity
contained in 10 mL of the NC-RS100 or NC-S100 formula-
tion) of the mixture of CCT/product 1 (9:1, w/w) in 10 mL
of ACN were analyzed to obtain their fluorescence profiles.
These samples were then diluted (10-fold) and analyzed.
Fluorescence microscopy
A human macrophage cell line was used as the cell model
to evaluate the fluorescent nanoparticle uptake. The hu-
man monocytic U937 cell line was cultured in suspension
in RPMI medium supplemented with 10% FBS at 37°C
under a 5% CO2 atmosphere. The cells were differentiated
into macrophages by seeding the cells, at a density of
5 × 104 cells per circular cover slip (diameter = 13 mm)
(Glasscyto, Brazil), and placing them into each plate
well (24-well plate), with resuspension in U937 medium
and supplementation with 10 nM PMA for 3 days at
37°C under 5% CO2 atmosphere. After this period, the
medium was removed and the adherent cells were
treated with the fluorescent nanoparticles (5 μL for
NC-RS100 and NC-S100 formulations and 10 μL for
LNC-PCL formulation), diluted in RPMI medium
(500 μL), corresponding to a density of approximately
4.3 to 6.5 × 1010 particles per mL (approximately
3.15 μg mL−1 of product 1) per well containing the
cover slip, and incubated for 2 h. A control group did
not receive any treatment. The cells were then washed
twice with PBS, fixed with a 2% glutaraldehyde/4%
paraformaldehyde solution (20 min), and again washed
twice with PBS. The cover slips were placed (cells
down) on microscope slides containing 10 μL of mounting
medium with DAPI to stain the cell nucleus. Cellular
imaging was carried out with a Nikon eclipse TE300
inverted fluorescent microscope (Nikon, Tokyo, Japan)
(×200 magnification) equipped with a digital camera.Standard filters for DAPI (blue) or rhodamine (red) were
used. The images were processed using the ImageJ pro-
gram, applying the same setting parameters (brightness and
contrast) to all samples, aiming to improve the blue and
red fluorescence intensity. The overlap of the channels (red
and blue) was achieved using the BioImageXD program.
Results
Synthesis of the product 1
The product 1 was obtained as a brilliant orange oily
product after the reaction of the vegetable oil with rhoda-
mine B in the presence of EDCI and DMAP (Figure 1)
followed by purification through column chromatography.
The TLC image in Figure 2 shows spots of CAO (a),
rhodamine B (b), the crude fluorescent product 1 (c),
and the purified fraction of the fluorescent product 1
(d) after revelation with UV light. As expected, the CAO
spot was not revealed. Rhodamine B eluted with a reten-
tion factor (Rf ) of 0.14. Besides the characteristic spot of
RhoB, several other spots can be observed for the elution
of the crude product 1 (c). No spot presenting the Rf of
RhoB was observed for the purified product 1 (d).
FTIR spectra of the starting raw materials of the reaction
(CAO and RhoB), as well as of the purified fluorescent
product 1, are shown in Figure 3. The product 1 (Figure 3
(A)) and CAO (Figure 3 (B)) showed similar FTIR spectra.
However, in the FTIR spectrum for the product 1 (Figure 3
(A)), no band was observed at 1,595 cm−1 [C =O (carbox-
ylic acid)] in contrast to the spectrum for the raw RhoB,
in which this peak was present (Figure 3 (C)). Regarding
the 1H-NMR spectrum, signals with a chemical shift at
low field (δ = 5.9 to 7) were observed only for the fluores-
cent product 1.
The UV-vis spectrum for the purified product 1 showed
λmax-ab at 519 nm. The spectrofluorimetry analysis was
then performed using the above-mentioned wavelength
for excitation of the samples. The emission spectrum for a
sample containing 1.52 mg mL−1 of the fluorescent product
1 presented λmax-em at 567 nm with an intensity of 340 a.u.
(Figure 4). Quantification of rhodamine B bound to the
rhodamine-labeled triglyceride (product 1) was performed
using the standard addition method (r > 0.99) indicating a
concentration of bound dye of 0.517 ± 0.096 μmol per g of
product 1.
The values for the Mw and number average molar mass
(Mn) were found to be 2,108 and 1,645 g mol−1, respect-
ively, obtained through SEC analysis of the purified product
1. For the raw castor oil sample, the corresponding values
were 2,120 g mol−1 (Mw) and 1,834 g mol−1 (Mn).
Characterization of the fluorescent nanocapsules and
fluorescent lipid-core nanocapsules
After their preparation, the pH values obtained for the for-
mulations were around 4.6 (NC-RS100), 3.5 (NC-S100),
Figure 1 General reaction scheme. Rhodamine B coupling with hydroxyl group of ricinolein contained in the castor oil using DMAP and EDCI
in dichloromethane to produce product 1.
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indicated a size distribution profile with the major particle
size fraction in the nanometer scale for all formulations
(Figure 5). The NC-S100 formulation presented a small
fraction of particles in the micrometer scale by volume
(Figure 5).(C)(B)(A) (D)
Figure 2 Thin layer chromatography (TLC) image. (A) Raw castor
oil, (B) rhodamine B, (C) crude fluorescent product 1, and (D) purified
fluorescent product 1.The D4.3 values observed for the nanoformulations
were around 150 nm (NC-RS100), 350 nm (NC-S100),
and 270 nm (LNC-PCL) (Table 1). SPAN values of 1.05
(NC-RS100), 2.28 (NC-S100), and 1.67 (LNC-PCL) were
obtained. The mean diameters of the formulations mea-
sured by PCS (z-average) were close to 200 nm with
polydispersity index (PDI) values lower than 0.34. The
zeta potential values were negative for the NC-S100
and LNC-PCL formulations and positive for the NC-
RS100 formulation. The concentrations of particles per
mL for each formulation were 5.56 ± 0.15 × 1012 parti-
cles (NC-RS100), 4.35 ± 0.41 × 1012 particles (NC-S100),
and 3.22 ± 0.58 × 1012 particles (LNC-PCL).
Figure 6 shows the fluorescence emission spectra obtained
for samples of the undiluted/unextracted (Figure 6A,B)
and diluted/extracted (Figure 6C,D) formulations. Solutions
containing the same quantities of the CCT/fluorescent
product 1 mixture as those in the LNC-PCL (solution





Figure 3 Infrared spectra. (A) purified product 1 (product 1), (B)
raw castor oil (CAO), and (C) rhodamine B (RhoB).





















Figure 4 Fluorescence emission spectrum of the synthesized
















Figure 5 Particle size distribution profiles by volume obtained
using laser diffraction (mean ± SD, n = 3).
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intensities of 346 and 642 a.u., respectively (Figure 6A,B).
Concentrated samples of the formulations NC-RS100 and
LNC-PCL (NC-RS100-1 and LNC-PCL-2) presented an
λmax-em value of 567 nm with intensities of 412 and 232 a.
u., respectively, while for NC-S100 (NC-S100-1), this value
was shifted to a higher wavelength (574 nm) compared to
that of the CCT/fluorescent product 1 mixture (9:1, w/w)
with an intensity of 464 nm (Figure 6A,B).
The λmax-em/If values for the diluted solutions (solution
3 and solution 4) of the primary solutions 1 and 2,
respectively, of the CCT/fluorescent product 1 mixture
were 567 nm/40 a.u. (solution 3) and 567 nm/75 a.u.
(solution 4) (Figure 6C,D). After diluting the nanocapsules
and lipid-core nanocapsule suspensions with ACN to
extract the fluorescent product 1, the NC-RS100 and LNC-
PCL samples (NC-RS100-2 and LNC-PCL-2) maintained
the value of λmax-em = 567 nm with fluorescence intensities
of 99 and 45 a.u., respectively. The diluted/extracted
NC-S100 sample (NC-S100-2) presented λmax-em/If values
of 569 nm/102 a.u.
Fluorescence microscopy
A cell uptake study was carried out to investigate the
potential for the fluorescence of the fluorescent nano-
particles to be used for localization in biological studies.
As demonstrated in the fluorescence characterization
of the fluorescent triglyceride-labeled nanocapsules andTable 1 Physicochemical characterization of the formulations
Sample pH D4.3 (nm) SPAN
LNC-PCL 4.91 ± 0.12 270 ± 85 1.67 ± 0.10
NC-RS100 4.60 ± 0.11 146 ± 9 1.05 ± 0.07
NC-S100 3.50 ± 0.09 344 ± 14 2.28 ± 0.03fluorescent triglyceride-labeled lipid-core nanocapsules,
the particles containing the fluorescent triglyceride (prod-
uct 1) presented red fluorescence (rhodamine B). The cell
nucleus appears in blue (DAPI). After 2 h of incubation,
red fluorescence was detected in the cells treated with
the fluorescent particles (NC-RS100, LNC-PCL, and
NC-S100) (Figure 7B,C,D). Fluorescence was not detected
in the cells that did not receive fluorescent nanocapsules
(control group) (Figure 7A).
Discussion
A rhodamine B-labeled triglyceride (product 1) was ob-
tained in order to prepare fluorescent nanocapsules with
different properties, such as anionic or cationic surfaces,
achieved by changing the polymer used to prepare the
nanocarrier. Fluorescent LNC were also prepared.
The RhoB carboxyl group was activated by a carbodii-
mide. This intermediate product reacted with the hydroxyl
groups of ricinolein, contained in the castor oil, to produce
an ester (product 1) (Figure 1). The fluorescent-labeled
product 1 was purified in a preparative chromatographic
column. The TLC (Figure 2) image, revealed with UV
light, indicated that a fluorescent product was obtained
without contamination of the unbound rhodamine B.
Thus, the purification process was effective in removing
molecules of rhodamine B that did not react with the
ricinolein from the crude fluorescent product 1. The(mean ± SD, n = 3)
z-average (nm) PDI ZP (mV)
198 ± 8 0.10 ± 0.02 −19.25 ± 4.16
170 ± 25 0.15 ± 0.08 +5.85 ± 0.56
207 ± 28 0.21 ± 0.13 −21.12 ± 6.45






























































































Figure 6 Fluorescence emission spectra of samples. (1) Fluorescence emission spectra of undiluted/unextracted samples of the formulations:
(A) LNC-PCL-1 compared to solution containing 160 μL (solution 1) of the CCT/fluorescent triglyceride product 1 mixture in 10 mL of ACN and (B)
NC-RS100-1 and NC-S100-1 compared to solution containing 333 μL (solution 2) of the CCT/fluorescent triglyceride product 1 mixture in 10 mL of
ACN. (2) Fluorescence emission spectra of diluted/extracted samples (10-fold in ACN) of the formulations: (C) LNC-PCL-2 compared to diluted solution
(10-fold) of solution 1 (solution 3) and (D) NC-RS100-2 and NC-S100-2 compared to diluted solution (10-fold) of solution 2 (solution 4).
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lead to release of the fluorescence from the nanocapsule
and thus unreliable results. The several spots observed for
the purified fluorescent product 1 were expected since
castor oil is a mixture of triglycerides and also because the
rhodamine B molecule can react with one, two, or three of
the hydroxyl groups presented in the ricinolein residue,
which could result in products with different polarities.
The FTIR and 1H-NMR spectra (Figure 3 and Additional
file 1: Figure S1B) showed that the main structure of the
raw castor oil was maintained after the reaction. No band
characteristic of carboxylic acid was observed on the FTIR
spectrum of the purified product (Figure 3), and the signal
with a chemical shift of 2.3, characteristic of the hydrogen
atoms of an ester, was maintained (Additional file 1:
Figure S1B). This suggests that no hydrolysis of the ester
bound occurred. 1H-NMR spectrum of the fluorescent
product 1 showed signals with chemicals shifts higher
than 5.8 and an AB system corresponding to the hydrogen
atoms of the aromatic ring of rhodamine B residue.
However, as previously reported, the sensitivity of FTIR
and 1H-NMR techniques can be not sufficient to detect
some functional groups or the protons of the dye due
to their small contribution compared to the contributionof the functions and hydrogen atoms of the oil residue
[12,28]. Up to this point, the results (TLC, FTIR, and 1H-
NMR) indicate that the functional carboxylic group of
rhodamine B was bound to the ricinolein presented in the
castor oil and that a fluorescent oily product was obtained
presenting good purity regarding the presence of unbound
rhodamine B.
UV-vis and fluorescence spectroscopy showed that
the product 1 obtained presents maximum absorption
(λmax-ab = 519 nm) in the green region of the optical
spectrum and maximum emission (Figure 4) in the yellow-
orange region (567 nm). The results for the SEC analysis
of the purified product 1 were consistent with the values
obtained for the raw castor oil, demonstrating that the
hydrodynamic volume and the size chain distribution
were not modified after rhodamine B coupling to the
product. The quantitative analysis of the amount of rhoda-
mine B bound to the product indicated a concentration of
bound dye of 0.517 ± 0.096 μmol per g of fluorescent oily
product (n = 3). This corresponds to 1 rhodamine residue
for 1,150 molecules of the product.
The rhodamine-labeled triglyceride was used to prepare
fluorescent NC formulations with Eudragit RS100 or
Eudragit S100, providing cationic and anionic particles,
Figure 7 Fluorescence microscopy images (magnification × 200) after the cell uptake study. Macrophage cells (A) with no treatment and
after treatment with (B) NC-RS100, (C) LNC-PCL, and (D) NC-S100. (1) Blue channel, (2) red channel, and (3) blue-red channel overlay. White scale
bar in D3 = 80 μm.
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the rhodamine-labeled product using poly(ε-caprolactone)
as the polymer. The liquid portion of the nanocapsule
core was composed of fluorescent triglyceride (10%) and
CCT (90%) (Table 1). In the LNC-PCL formulations, the
liquid portion was 160 μL/10 mL of suspension corre-
sponding to approximately 1.52 mg of fluorescent product
per mL of suspension, while in NC-RS100 and in NC-
S100, the liquid portion was 333 μL/10 mL of suspension
corresponding to approximately 3.15 mg of fluorescent
product per mL of suspension. It is important to note
that the amount of rhodamine-labeled triglyceride canbe increased or decreased, according to the needs of the
study. The pH of the nanocapsule formulations (Table 1)
was slightly acid and similar to the values previously
reported for formulations prepared without the fluorescent-
labeled oil [26,29]. The size distribution profiles (Figure 5)
and the D4.3, SPAN, z-average, PDI, and zeta potential
values for the formulations containing the fluorescent
product 1 (Table 1) did not differ considerably from those
observed for non-fluorescent formulations [25-27].
The zeta potential values for the formulations prepared
with the fluorescent product 1 (Table 1) showed values
approximately closed to those previously reported for
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oil [25-27]. The electrokinetic behavior of colloids is
related to the movement of ionic solutions near charged
interfaces [30]. The carboxylic acids, as pendant groups in
Eudragit S100 or as terminal groups in PCL116, are in an
acid-base balance at the particle-water interface producing
carboxylate functions that react with NaCl forming the
electrical double layer responsible for the eletrokinetic
behavior of NC-S100 and LNC-PCL. On the other
hand, the NC-RS has a polymer wall of poly(ethyl
acrylate-co-methyl methacrylate-co-trimethylammonioethyl
methacrylate chloride), whose monomer units are at 1:2:0.1
proportions. In this way, the trimethylammonioethyl moi-
ety has a quaternary nitrogen giving to the particle-water
interface a positive charge. The electrokinetic properties of
NC-RS are related to the positive surface potential that
those nanocapsules present after dilution in 10 mmol L−1
NaCl aqueous solution. Considering that all formulations
contain polysorbate 80, the mechanism of stabilization
of those colloids is not exclusively based on the electrical
repulsion of the particles since the steric hindrance effect
of the surfactant plays an important role [31-33]. Then,
even though the zeta potential values are near zero for
all formulations, the colloidal turbid solutions have an
adequate kinetic stability for the purpose of drug delivery.
The NC-RS100 and NC-S100 formulations presented
higher concentrations of particles (approximately 1.7-fold
and 1.4-fold, respectively) than LNC-PCL (P < 0.05). This
result was expected since the volumetric fraction of the
dispersed phase in these formulations is higher than that
of LNC-PCL, and the z-average values obtained for each
formulation were similar [8].
The fluorescence spectroscopy analysis of the fluores-
cent nanocapsules and fluorescent lipid-core nanocapsules
showed that the fluorescence property is maintained after
the preparation of these formulations (Figure 6). The
difference in the fluorescence intensity on comparing
the NC-RS100 and NC-S100 formulations with LNC-PCL
was expected since the concentration of fluorescent prod-
uct in these formulations varied (approximately 3.15 mg
of product 1/mL of suspension for NC-RS100 and NC-
S100 and approximately 1.52 mg of product 1/mL of
suspension for LNC-PCL) (Figure 6). In the undiluted/
unextracted samples of the formulations, it was seen
that the bathochromic (7 nm) shift for the λmax-em value
in the emission spectrum of the NC-S100-1 formulation
was accompanied by a hyperchromic shift (52 a.u.) when
compared to the NC-RS100-1 formulation, which contains
the same quantity of fluorescent product, probably due to
protonation of the amino group of rhodamine B, as the pH
of this formulation was the lowest among the formulations
(3.50 ± 0.09). As previously reported, rhodamine B has
an equilibrium of isoforms, lactonic and the zwitterionic
isomers [34]. The zwitterion isomer can be protonatedmore than once due to the presence of two amino groups
[34]. A hypochromic shift was observed in the emission
spectra of the undiluted/unextracted samples of the
LNC-PCL-1 (114 a.u.), NC-RS100-1 (230 a.u.), and NC-
S100-1 (178 a.u.) formulations compared to the spectrum
of the solutions containing the same quantity of the
CCT/fluorescent oily product mixture in ACN [solution 1
(1.52 mg/mL) and solution 2 (3.15 mg/mL)] (Figure 6A,
B). Unsurprisingly, in the case of the samples containing
the CCT/fluorescent oily product mixture (Figure 6C,D),
the results for the fluorescence intensity of the diluted/
extracted samples of the formulations showed greater
similarity when compared to the undiluted/unextracted
samples. The previously observed hypochromic shift did
not occur and a small hyperchromic shift occurred, espe-
cially for NC-RS100-2 (24 a.u.) and NC-S100-2 (27 a.u.).
Therefore, these changes in the fluorescence intensity of
the undiluted/unextracted samples are probably related to
the volume fraction of particles in the dispersed phase of
the formulation leading to phenomena such as the inner
filter effect, where the presence of other compounds can
partially absorb the emission energy, and they were not
sufficiently reduced even with the use of a triangular
cuvette [35,36].
To demonstrate the applicability of the synthesized
fluorescent triglyceride (product 1) to the identification
of particles containing this compound in image studies,
a cell uptake study was performed. It was possible to
observe red fluorescence in the cells treated with the
fluorescent nanoparticles (Figure 7). The red fluorescence
was very close to the cell nucleus suggesting that the parti-
cles are located inside the cells. Martins and co-workers
[37] have reported the uptake of solid lipid nanoparticles
(SLN) stabilized with polysorbate 80 by THP1-derived
macrophages. The authors loaded the SLN with a green
fluorescent dye and evaluated the particle uptake by
fluorescence microscopy. In a recent study, our research
group demonstrated the uptake of LNC-PCL, also stabi-
lized with polysorbate 80, by macrophages isolated from
BALB/c mice [11]. In this case, the LNC-PCL particles
were prepared with the polymer chemically bound to
rhodamine-B and non-labeled oil. The results reported
herein reinforce these findings and can demonstrate the
applicability of the use of the fluorescent triglyceride to
localize particles in biological studies with the advantage
of allowing the development of tracking systems with
surfaces exhibiting a variety of chemical natures. In a
forthcoming publication, the applicability of this product
to tracking particle skin penetration and also particle
uptake by skin cells, considering the influence of the
particle surface properties, will be demonstrated.
Recently, in an in vivo study with rats implanted with
glioma tumors, it was showed that, after 10 days of treat-
ment, the group of animals treated with indomethacin
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concentration of the drug in the cerebral tissue and,
more specifically, in the tumor hemisphere compared
to the group which received the free drug [2]. The
tumor size of the groups treated with IndOH-LNC [2]
or trans-resveratrol loaded in LNC (t-resv-LNC) [38]
particles was significantly reduced when compared to
the groups treated with the free drug. A similar profile
of higher drug concentration in the brain compared to
the free drug was observed in a biodistribution study in
rats treated with trans-resveratrol or t-resv-LNC particles
[39]. Based on these findings, it is suggested that LNC
particles are able to target the drug to the brain tissue
and reduce the tumor size. The synthesis of fluorescent
materials for the preparation of fluorescent dye-labeled
nanocapsules, such as the fluorescent polymer [12] and
the fluorescent triglyceride, product 1 (as reported herein),
could also be useful for tracking the pathway of the LNC
particles and/or their uptake in cells, for instance, in
experiments similar to those cited here. Therefore, the
labeled nanoparticles may be used to find the final destiny
of the particles after in vitro and in vivo treatments.Conclusions
A fluorescent oily product, rhodamine-labeled triglyceride,
was obtained without unbound rhodamine B. The product
was used to prepare fluorescent polymeric nanocapsules
with cationic or anionic surface charges. The results
obtained for the physicochemical characterization of the
fluorescent-labeled nanocapsules and fluorescent-labeled
lipid-core nanocapsules were similar to those previously
reported for formulations prepared without the fluores-
cent product indicating that the labeling did not affect
the characteristics of the nanocarriers. Thus, our results
indicate the possibility of obtaining versatile dye-labeled
polymeric vesicular nanocarriers, with surfaces exhibiting
different chemical natures, applying the strategy of fluor-
escent dye labeling of the triglyceride which forms the
oily inner core of the nanocapsules. This fluorescent
dye-labeled triglyceride could be used for particle local-
ization in biological studies with the advantage among
other fluorescent materials that any carrier that con-
tains a triglyceride in its formulation composition can
be obtained and tracked.Additional file
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